Ani Pharmaceuticals Inc (ANIP)
Depreciation & Amortization
$85.80M
TTM · Period ending: · USD
ANIP Depreciation & Amortization
Latest reported$85.80Mperiod ending
Latest reported$85.80Mperiod ending
ANIP TTM Depreciation & Amortization ($122.79K → $85.80M)
TTM Depreciation & Amortization
High-resolution chart · PNG
ANIP depreciation & amortization history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Depreciation & Amortization (USD) |
|---|---|
| 85,804,000 | |
| 89,445,000 | |
| 91,417,000 | |
| 91,404,000 | |
| 84,520,000 | |
| 75,936,000 | |
| 67,731,000 | |
| 60,325,000 | |
| 59,784,000 | |
| 59,777,000 | |
| 59,791,000 | |
| 60,169,000 | |
| 60,312,000 | |
| 59,796,000 | |
| 59,653,000 | |
| 57,765,000 | |
| 53,761,000 | |
| 50,911,000 | |
| 47,252,000 | |
| 44,467,000 | |
| 44,479,000 | |
| 44,353,000 | |
| 44,638,000 | |
| 43,303,000 | |
| 41,418,000 | |
| 39,692,000 | |
| 44,612,000 | |
| 43,734,000 | |
| 42,809,000 | |
| 41,650,000 | |
| 33,742,000 | |
| 32,078,000 | |
| 30,629,000 | |
| 29,417,000 | |
| 27,928,000 | |
| 26,718,000 | |
| 25,585,000 | |
| 24,440,000 | |
| 22,343,000 | |
| 18,642,000 | |
| 14,723,000 | |
| 10,182,000 | |
| 6,900,000 | |
| 6,071,000 | |
| 5,211,000 | |
| 4,502,000 | |
| 3,878,000 | |
| 3,033,172 | |
| 2,227,871 | |
| 1,646,614 | |
| 1,110,000 | |
| 844,226 | |
| 488,276 | |
| 394,466 | |
| 258,946 | |
| 117,656 | |
| 127,576 | |
| 137,162 | |
| 148,240 | |
| 157,151 | |
| 162,482 | |
| 164,509 | |
| 167,986 | |
| 170,360 | |
| 162,668 | |
| 153,455 | |
| 137,280 | |
| 105,183 | |
| 83,634 | |
| 62,610 | |
| 43,137 | |
| 44,156 | |
| 50,390 | |
| 66,681 | |
| 89,824 | |
| 111,999 | |
| 124,731 | |
| 123,240 | |
| 117,781 | |
| 109,780 | |
| 104,519 | |
| 103,452 | |
| 100,938 | |
| 103,171 | |
| 103,905 | |
| 103,603 | |
| 101,943 | |
| 98,026 | |
| 94,854 | |
| 92,662 | |
| 92,927 | |
| 93,665 | |
| 93,836 | |
| 92,985 | |
| 92,099 | |
| 91,148 | |
| 89,409 | |
| 100,260 | |
| 110,560 | |
| 137,391 |